Pharma Components ApS: Financial statements 2023
CVR: 39103079
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharma Components ApS (CVR 39103079) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 232,225 and a net result of DKK 196,140 compared with DKK 57,077 the year before. That is an increase of 238.8% compared with the year before. Equity in the 2023 report amounted to DKK 245,518. The solvency ratio was 39.2%.
- Gross Profit
- DKK 232,225
- Profit/Loss
- DKK 196,140
- Equity
- DKK 245,518
- Total Assets
- DKK 626,921
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 232 t. | 196 t. | 246 t. | 0 |
| 2022 | - | 69 t. | 57 t. | 49 t. | 0 |
| 2021 | - | -22 t. | -23 t. | -8 t. | 0 |
| 2020 | - | -17 t. | -15 t. | 15 t. | 0 |
| 2019 | - | 45 t. | 35 t. | 31 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of June 28, 2023, Anders Fossing Riel has joined the board of directors of Pharma Components ApS.
As of June 28, 2023, Anders Fossing Riel is registered as adm. dir. of Pharma Components ApS.
As of June 28, 2023, Patrick Lund Ossian has stepped down as adm. dir. of Pharma Components ApS.
As of June 28, 2023, A.Rocket Holding ApS is registered as an owner of Pharma Components ApS with an ownership share of 100%.
Pharma Components ApS has published its annual report for 2022. Gross profit came to DKK 68,538, and the net result was DKK 57,077.
About Pharma Components ApS
Pharma Components ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Pharma Components IVS. The management consists of Anders Fossing Riel. The company is owned by A.Rocket Holding ApS. In 2025, the company reported a gross profit of DKK -35,183 and a net result of DKK -115,173 compared with DKK 142,048 the year before. Equity in the 2025 report amounted to DKK 272,393.